Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
8
PPB:8
Drug Approvals
PNUPREVE23 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PRE-FILLED SYRINGE 0.5ML
- Approval Date
- Mar 19, 2025
PPB
CORONAVAC COVID-19 VACCINE (VERO CELL), INACTIVATED 0.5ML/DOSE 0.5ML VIAL
- Approval Date
- Dec 16, 2022
PPB
CORONAVAC COVID-19 VACCINE (VERO CELL), INACTIVATED 0.5ML/DOSE 0.5ML PRE-FILLED SYRINGE
- Approval Date
- Dec 16, 2022
PPB
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Immunogenicity and Safety Study of Booster Vaccine With the COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
Phase 2
Completed
- Conditions
- COVID-19
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Sinovac Biotech (Hong Kong) Limited
- Target Recruit Count
- 221
- Registration Number
- NCT05411471
- Locations
- 🇨🇳
Gleneagles Hospital HongKong, Hong Kong, China
News
No news found